Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
Open Access
- 28 January 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (7), 2611-2616
- https://doi.org/10.1073/pnas.1300057110
Abstract
Over the last two decades, we have extensively studied the genetics of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency (CAH) and have performed 8,290 DNA analyses of the CYP21A2 gene on members of 4,857 families at risk for CAH—the largest cohort of CAH patients reported to date. Of the families studied, 1,507 had at least one member affected with one of three known forms of CAH, namely salt wasting, simple virilizing, or nonclassical CAH. Here, we report the genotype and phenotype of each affected patient, as well as the ethnic group and country of origin for each patient. We showed that 21 of 45 genotypes yielded a phenotypic correlation in our patient cohort. In particular, contrary to what is generally reported in the literature, we found that certain mutations, for example, the P30L, I2G, and I172N mutations, yielded different CAH phenotypes. In salt wasting and nonclassical CAH, a phenotype can be attributed to a genotype; however, in simple virilizing CAH, we observe wide phenotypic variability, particularly with the exon 4 I172N mutation. Finally, there was a high frequency of homozygous I2G and V281L mutations in Middle Eastern and Ashkenazi Jewish populations, respectively. By identifying the predominant phenotype for a given genotype, these findings should assist physicians in prenatal diagnosis and genetic counseling of parents who are at risk for having a child with CAH.Keywords
This publication has 49 references indexed in Scilit:
- Mutation Analysis of theCYP21A2Gene in the Iranian PopulationGenetic Testing and Molecular Biomarkers, 2012
- Steroid 21‐hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype–phenotype correlation in a large cohort of patients with congenital adrenal hyperplasiaClinical Endocrinology, 2011
- Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2011
- Molecular Defects of the CYP21A2 Gene in Greek-Cypriot Patients with Congenital Adrenal HyperplasiaHormone Research in Paediatrics, 2010
- Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatmentActa Paediatrica, 2007
- Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypesHuman Genetics, 2002
- Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) Without Demonstrable Genetic MutationsJournal of Clinical Endocrinology & Metabolism, 1999
- Synergistic Effect of Partially Inactivating Mutations in Steroid 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 1997
- Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.JCI Insight, 1992
- A rapid method for determining sequences in DNA by primed synthesis with DNA polymeraseJournal of Molecular Biology, 1975